1. Drug Repositioning for Effective Prostate Cancer Treatment
   Beste Turanli et al, 2018, Front. Physiol. CrossRef
2. Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines
   Dorota Olender et al, 2018, Pharmaceuticals CrossRef
3. In Search of a Breakthrough Therapy for Glioblastoma Multiforme
   Alex Vasilev et al, 2018, Neuroglia CrossRef
4. Chitosan Oligosaccharides Induce Apoptosis in Human Renal Carcinoma via Reactive-Oxygen-Species-Dependent Endoplasmic Reticulum Stress
   Xingchen Zhai et al, 2019, J. Agric. Food Chem. CrossRef
5. Nitroxoline induces cell apoptosis by inducing MDM2 degradation in small‐cell lung cancer
   Jin‐Guo Yu et al, 2019, Kaohsiung J Med Sci CrossRef
6. Discovery and Structure-Based Optimization of Next Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors
   Timo Heinrich et al, 2019, J. Med. Chem. CrossRef
7. null
   Alex G. Dalecki et al, 2017 CrossRef
8. A Novel Electrochemical Sensing of 8-Hydroxy-5-Nitro-Quinoline Moiety using Graphene-Oxide Fabricated Glassy Carbon Electrode
   Varsha Jakhar et al, 2019, Analytical Chemistry Letters CrossRef
9. WX-132-18B, a novel microtubule inhibitor, exhibits promising anti-tumor effects
   Fang Guan et al, 2017, Oncotarget CrossRef
10. Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo
    Ana Mitrović et al, 2017, Oncotarget CrossRef
11. Targeted Nanoparticles for Co-delivery of 5-FU and Nitroxoline, a Cathepsin B Inhibitor, in HepG2 Cells of Hepatocellular Carcinoma
    Jaleh Varshosaz et al, 2020, ACAMC CrossRef
12. Overcoming cancer therapeutic bottleneck by drug repurposing
    Zhe Zhang et al, 2020, Sig Transduct Target Ther CrossRef
13. New drugs are not enough‑drug repositioning in oncology: An update.
    Romina Gabriela Armando et al, 2020, Int J Oncol CrossRef
14. null
    Süreyya Ölgen, 2020 CrossRef
15. Rationally repurposed nitroxoline inhibits preclinical models of Epstein–Barr virus-associated lymphoproliferation
    Maite Ibáñez de Garayo et al, 2021, J Antibiot CrossRef
16. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
    Christina Pfab et al, 2021, Cancers CrossRef
17. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates
    Laura De Lellis et al, 2021, Cancers CrossRef
18. Camouflaged liposomes by 11A4-nanobody for co-delivery of cisplatin and nitroxoline in breast cancer tumors: An in vitro/in vivo study
    Leila Sayed-Tabatabaei et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
19. Nitroxoline Drug Combinations Are More Active Than Lyme Antibiotic Combination and Can Eradicate Stationary-Phase Borrelia burgdorferi
    Hector S. Alvarez-Manzo et al, 2022, Infect Microb Dis CrossRef
20. Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines
    Eduarda Ribeiro et al, 2023, Biomedicines CrossRef
21. Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
    Faheem Ahmed et al, 2023, Journal of Medical Virology CrossRef
22. null
    Subrata Das et al, 2023 CrossRef
23. Induction of Programmed Cell Death in Acanthamoeba culbertsoni by the Repurposed Compound Nitroxoline
    Rubén L. Rodríguez-Expósito et al, 2023, Antioxidants CrossRef
24. A quality‐by‐design evaluated liquid chromatography method development and validation for the separation and quantification of nitroxoline and its impurities
    Santhi Priya Lankalapalli et al, 2023, J of Separation Science CrossRef
25. null
    Juni Banerjee et al, 2024 CrossRef
26. Enhancing Urological Cancer Treatment: Leveraging Vasodilator Synergistic Potential with 5-FU for Improved Therapeutic Outcomes
    Eduarda Ribeiro et al, 2024, JCM CrossRef